Medartis Holding Net Income Over Time
| MED Stock | 93.20 5.00 5.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medartis Holding Performance and Medartis Holding Correlation. Medartis |
Cross Equities Net Income Analysis
Compare Medartis Holding and related stocks such as COSMO Pharmaceuticals, Aevis Victoria SA, and SKAN Group AG Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COPN | (2.2 M) | 7.6 M | 19.3 M | 68.7 M | 73.3 M | 248.2 M | 19.3 M | (32.4 M) | (18.1 M) | (24.5 M) | (7.9 M) | 21.7 M | 17.2 M | (4.9 M) | 133.2 M | 153.2 M | 160.9 M |
| AEVS | (1.8 M) | 471 K | 3.3 M | 8.7 M | 6.1 M | 3.8 M | 2.3 M | (922 K) | (8.7 M) | 163.2 M | (31.8 M) | (4.3 M) | 58.8 M | (39.3 M) | (2.9 M) | (3.3 M) | (3.1 M) |
| SKAN | 3.5 M | 3.5 M | 3.5 M | 2.2 M | 4.5 M | 18.4 M | 16 M | 15.2 M | 5.8 M | 18 M | 4.5 M | 10.6 M | 19 M | 26.3 M | 38.8 M | 44.6 M | 46.9 M |
| KURN | (23.9 M) | (18.8 M) | (9.2 M) | (30.8 M) | (34 M) | 6.2 M | (19.7 M) | (16.5 M) | (11.7 M) | (11.3 M) | (11.5 M) | (7.5 M) | (14.6 M) | (13.7 M) | (3.7 M) | (4.3 M) | (4.5 M) |
| IDIA | (335.1 M) | (335.1 M) | (335.1 M) | (335.1 M) | (335.1 M) | (335.1 M) | (335.1 M) | (14.3 M) | (386.4 M) | (494.6 M) | (445.1 M) | (634.6 M) | (827.9 M) | (297.9 M) | (263.8 M) | (237.4 M) | (249.3 M) |
| PPGN | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 25.7 M | 31.3 M | 47.3 M | 7.8 M | (51.4 M) | (19.6 M) | (17.6 M) | (16.7 M) |
| BSLN | (59 M) | (57.6 M) | (53 M) | (33 M) | (41.5 M) | (61.6 M) | (51.3 M) | (19.4 M) | (31.4 M) | (22.4 M) | (14.7 M) | (6.8 M) | 12.1 M | 10.5 M | 77.6 M | 40.2 M | 42.2 M |
| DOCM | 3.9 M | 8.7 M | 6.2 M | (15.5 M) | 7.2 M | 3.4 M | (12.8 M) | (36.2 M) | (39 M) | (52.4 M) | (135.7 M) | (225.7 M) | (171.1 M) | 82.3 M | (97.3 M) | (87.5 M) | (83.2 M) |
| VBSN | 3.3 M | 13.2 M | 14.8 M | 15.3 M | 15.8 M | 16.1 M | 16.4 M | 16 M | 14.1 M | 12.2 M | 17.8 M | 6.2 M | 11.2 M | 15.1 M | 20.3 M | 23.3 M | 12.7 M |
| CLTN | 13.3 M | 6 M | 9.5 M | 13.2 M | 15.6 M | 13.3 M | 17.3 M | 19.1 M | 14.9 M | 20 M | 8.2 M | 31.7 M | 26 M | 11.9 M | 20.5 M | 18.4 M | 14.5 M |
Medartis Holding and related stocks such as COSMO Pharmaceuticals, Aevis Victoria SA, and SKAN Group AG Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Medartis Holding financial statement analysis. It represents the amount of money remaining after all of Medartis Holding AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Medartis Holding AG | MED |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Hochbergerstrasse 60E, Basel, |
| Exchange | SIX Swiss Exchange |
null 93.2
Additional Tools for Medartis Stock Analysis
When running Medartis Holding's price analysis, check to measure Medartis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medartis Holding is operating at the current time. Most of Medartis Holding's value examination focuses on studying past and present price action to predict the probability of Medartis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medartis Holding's price. Additionally, you may evaluate how the addition of Medartis Holding to your portfolios can decrease your overall portfolio volatility.